Key facts
- WELLINGTON MANAGEMENT GROUP LLP filed SCHEDULE 13G for Soleno Therapeutics, Inc. Common Stock (SLNO).
- Disclosed ownership: 6.2%.
- Date of event: 31 Dec 2025.
WELLINGTON MANAGEMENT GROUP LLP - 31 Dec 2025 SCHEDULE 13G Report for Soleno Therapeutics, Inc. Common Stock (SLNO)
- Filing Manager
- WELLINGTON MANAGEMENT GROUP LLP
- Reporting Manager
- Wellington Management Group LLP
- Symbol
- SLNO
- Shares outstanding
- 53,593,532 shares
- Disclosed Ownership
- 3,322,799 shares
- Ownership
- 6.2%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Feb 2026, 11:17:43 UTC
- Date of event
- 31 Dec 2025
- Next filing
- 15 May 2026
- SEC
- View on sec.gov
Key filing fact
WELLINGTON MANAGEMENT GROUP LLP disclosed 6.2% ownership in Soleno Therapeutics, Inc. Common Stock (SLNO) on 31 Dec 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Feb 2026, 11:17.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (4)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Wellington Management Group LLP | 6.2% | 3,322,799 | 0 | 3,088,720 | Taisia Lowe | Regulatory Analyst | |
| Wellington Group Holdings LLP | 6.2% | 3,322,799 | 0 | 3,088,720 | Taisia Lowe | Regulatory Analyst | |
| Wellington Investment Advisors Holdings LLP | 6.2% | 3,322,799 | 0 | 3,088,720 | Taisia Lowe | Regulatory Analyst | |
| Wellington Management Company LLP | 6% | 3,322,799 | 0 | 3,081,174 | Taisia Lowe | Regulatory Analyst |
CIK / CUSIP context first